Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer
Howard I. Scher, Andrew J. Armstrong, Joseph D. Schonhoft, Anthony J. Gill, Jimmy L. Zhao, E. Barnett, Emily Carbone, Jieyang Lu, Emmanuel S. Antonarakis, Jun Luo, Scott T. Tagawa, Carlos Henrique dos Anjos, Qian Yang, Daniel J. George, Russell Z. Szmulewitz, Daniel C. Danila, Rick Wenstrup, Mithat Gönen, Susan Halabi
Topics & Concepts
Prostate cancerMedicineEnzalutamideHazard ratioOncologyCohortCirculating tumor cellInternal medicineBiomarkerProportional hazards modelCancerAbiraterone acetateAndrogen receptorConfidence intervalAndrogen deprivation therapyMetastasisBiologyBiochemistryProstate Cancer Treatment and ResearchCancer Cells and MetastasisCancer Genomics and Diagnostics